$GILD Recent Headlines Hopes for single-dose Hepatitis

New Post Public Reply Private Reply Replies (0) Message Board

Feb 11, 2015 at 9:54 AM

$GILD Recent Headlines

Hopes for single-dose Hepatitis C drug fade 3:30 p.m. Feb. 9, 2015 - Russ Britt
McKesson revenue buoyed by Hep C drugs 4:54 p.m. Feb. 5, 2015 - MarketWatch.com
The best way to get into the drug-distribution space 1:20 p.m. Feb. 5, 2015 - The Trading Deck
Keurig Green Mountain burned by weak outlook, sales 6:35 p.m. Feb. 4, 2015 - Sue Chang
U.S. stocks end lower as ECB reject Greek bonds as collateral 4:33 p.m. Feb. 4, 2015 - Barbara Kollmeyer
Gilead to discount its pricey Sovaldi drug 1:55 p.m. Feb. 4, 2015 - Russ Britt
Gilead Sciences shares tumble 9.7% 9:33 a.m. Feb. 4, 2015 - Sue Chang
Careful what you wish for: Oil-price recovery may sting 8:28 a.m. Feb. 4, 2015 - Shawn Langlois
Disney shares rise after earnings beat 6:20 p.m. Feb. 3, 2015 - Sue Chang
Gilead earnings beat views by 20 cents a share 4:32 p.m. Feb. 3, 2015 - Russ Britt
Updates, advisories and surprises 4:31 p.m. Feb. 3, 2015 - MarketWatch
Gilead Sciences profit surges on Hep-C drugs 4:20 p.m. Feb. 3, 2015 - MarketWatch.com
Gilead earnings beats views by 20 cents a share 4:18 p.m. Feb. 3, 2015 - Russ Britt
Gilead revs. of $7.3B beats view of $6.72B 4:09 p.m. Feb. 3, 2015 - Russ Britt
Gilead revs. $7.32B vs. year-ago $3.12B 4:09 p.m. Feb. 3, 2015 - Russ Britt
Gilead net is $2.18/share vs. year-ago 47 cents/share 4:08 p.m. Feb. 3, 2015 - Russ Britt
Gilead net is $2.18/share vs. year-ago 47 cents/share 4:08 p.m. Feb. 3, 2015 - Russ Britt
Gilead adj. earns $2.43/share vs. $2.23/share view 4:07 p.m. Feb. 3, 2015 - Russ Britt
What to look for in Gilead earnings 11:26 a.m. Feb. 3, 2015 - Russ Britt
Bulls looking for a lift as things aren’t going by the playbook 6:39 a.m. Feb. 3, 2015 - Shawn Langlois

Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price 50 min ago - TheStreet.com
Short Sellers Look Scared of Big Biotech 8:52 a.m. Today - 247WallSt.com
No Overseas Noise Is Good For America - Cramer's Mad Money (2/10/15) 7:38 a.m. Today - Seeking Alpha
InsiderInsights.com Daily Round Up 2/10/15: ZIOP, WMS, R, MLNK 4:29 a.m. Today - Seeking Alpha
The Dividend Growth 50... Plus 111 More 6:31 p.m. Feb. 10, 2015 - Seeking Alpha
The Dividend Growth 50... Plus 113 More 6:31 p.m. Feb. 10, 2015 - Seeking Alpha
Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial 11:36 a.m. Feb. 10, 2015 - GuruFocus.com
Gilead Walloped by Lower Pricing View on Hepatitis C 10:59 a.m. Feb. 10, 2015 - Barrons.com
Bad News For Gilead Sciences Is Great News For Investors 9:39 a.m. Feb. 10, 2015 - Seeking Alpha
Obama's Proposal To Allow Government To Negotiate Treatment Prices Creates New Questions For Drug Makers 7:55 a.m. Feb. 10, 2015 - benzinga.com
Total Return Of Stocks With The Largest Following On Seeking Alpha 7:42 a.m. Feb. 10, 2015 - Seeking Alpha
European charity uses legal challenge to improve access to Sovaldi 7:34 a.m. Feb. 10, 2015 - Seeking Alpha
Career Booster for CFOs: Work Experience Abroad 12:01 a.m. Feb. 10, 2015 - The Wall Street Journal Interactive Edition
Jim Cramer's 'Mad Money' Recap: Stop Worrying About the Fed Rate Increase 8:53 p.m. Feb. 9, 2015 - TheStreet.com
Going Overweight With Gilead In My DGI Portfolio 4:33 p.m. Feb. 9, 2015 - Seeking Alpha
Achillion Soars on 6 Week HCV Cure When Used with Gilead's Sofosbuvir - Stocks in the News 3:38 p.m. Feb. 9, 2015 - Zacks.com
Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More 3:21 p.m. Feb. 9, 2015 - TheStreet.com
Gilead Sciences Could Be A Dividend Growth Stock 3:04 p.m. Feb. 9, 2015 - Seeking Alpha
Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown 10:46 a.m. Feb. 9, 2015 - benzinga.com
Regulus' Dream of a Single-Shot Hepatitis C Cure Falls Short 10:05 a.m. Feb. 9, 2015 - TheStreet.com

Patience Pays Off for Opko and Cocrystal Investors, Will It Also for Pershing Gold? 27 min ago - ACCESSWIRE
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 9, 2015 - BusinessWire - BZX
Mobiquity Invests $20 Million in London Healthcare, Joins London Mayor in MedCity Initiative and Gilead Sciences 1:07 p.m. Feb. 9, 2015 - Marketwired
Earnings Forecast Research for Alibaba, Frontier, Akamai Technologies, Gilead Sciences, Halliburton, and Freeport-McMoRan 8:45 a.m. Feb. 9, 2015 - PR Newswire - PRF
Health Care Leaders Call for Sustainable Pricing as Senate Health Committee Shines Spotlight on Six-Figure Specialty Drugs 4:51 p.m. Feb. 4, 2015 - PR Newswire - PRF
Earnings Forecast Alerts for Apple, Alibaba, Stratasys, Gilead Sciences, Cliffs Natural Resources, and Bank of America 8:45 a.m. Feb. 4, 2015 - PR Newswire - PRF
Gilead Sciences Announces 43 Cents Quarterly Dividend Program and $15 Billion Share Buyback Program 4:06 p.m. Feb. 3, 2015 - BusinessWire - BZX
Critical Alerts For Amazon.com, JetBlue, KB Home, Stratasys and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Jan. 30, 2015 - PR Newswire - PRF
Earnings Forecast Buzz for Fannie Mae, Apple, Yahoo, Alibaba, Gilead Sciences, and Bank of America 8:45 a.m. Jan. 29, 2015 - PR Newswire - PRF
Gilead Announces Executive Promotions 4:30 p.m. Jan. 28, 2015 - BusinessWire - BZX
Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015 5:00 p.m. Jan. 27, 2015 - BusinessWire - BZX
EnvisionRx and Gilead Sciences Sign Exclusive Agreement to Help in the Fight Against Hepatitis C 1:00 p.m. Jan. 26, 2015 - BusinessWire - BZX
Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent 10:58 a.m. Jan. 26, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Alibaba, FXCM, Gilead Sciences, Freeport-McMoRan, and Bank of America 8:45 a.m. Jan. 26, 2015 - PR Newswire - PRF
Morningstar Names John Martin of Gilead Sciences as its 2014 CEO of the Year 1:06 p.m. Jan. 21, 2015 - PR Newswire - PRF
Critical Alerts For Mobileye NV, Kandi Technologies, Gilead Sciences, Petrobras and Noodles & Company Released By InvestorsObserver 9:31 a.m. Jan. 20, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Intel, Alibaba, Bank of America, Activision Blizzard, and Gilead Sciences 8:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert 6:15 a.m. Jan. 20, 2015 - Marketwired
Earnings Forecast Research for Apple, Bank of America, Freeport-McMoRan, Agenus, Alibaba, and Sirius XM 8:45 a.m. Jan. 14, 2015 - PR Newswire - PRF
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 5:00 p.m. Jan. 12, 2015 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PZZA Faces Class Action: Strategic Shake-up or Misstep?

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Aberdeen's Reverse Split: What Investors Need to Know

Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...

Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Csquare Investors Face Tough Questions Amid Probe

Csquare's Shaky Claims and Market Consequences When a company flashes big numbers like $356 million to showcase its financial health, it sure gets the ticker NYSE:CSQR buzzing. But here's the rub—over half of that is locked up tighter than a drum, off-limits for general use. You gotta appreciate the irony, right? Someone's turned up a rock and there it is, a mess of...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Veterans Find Community and Wellness at Orland Hills Bash

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...